Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
JAMA|January 15, 2004
Transmission and clinical features of enterovirus 71 infections in household contacts in TaiwanLuan-Yin Chang, Kou-Chien Tsao, Shao-Hsuan Hsia, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2012
Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with non-small-cell lung cancerKang-Yi Su, Hsuan-Yu Chen, Ker-Chau Li, et al.
Cancer Chemotherapy and Pharmacology|July 29, 2022
A dose regimen-finding study to evaluate the safety, tolerability, pharmacokinetics, and activity of oratecan in subjects with advanced malignanciesPatrick M Boland, Christos Fountzilas, Marwan Fakih, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Targeting neuropilin 1 as an antitumor strategy in lung cancerTse-Ming Hong, Yuh-Ling Chen, Yi-Ying Wu, et al.
Cancer Chemotherapy and Pharmacology|June 22, 2022
A phase Ib study of Oraxol (oral paclitaxel and encequidar) in patients with advanced malignanciesWen Wee Ma, Jenny J Li, Nilofer S Azad, et al.
Nature Cell Biology|May 19, 2009
p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of SlugShu-Ping Wang, Wen-Lung Wang, Yih-Leong Chang, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 26, 2022
Population pharmacokinetics for oral paclitaxel in patients with advanced/metastatic solid tumorsJimmy He, Christopher G C A Jackson, Sanjeev Deva, et al.
Journal of Surgical Oncology|February 24, 2005
Pre-operative chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancerLing-Wei Wang, Shung-Haur Yang, Jen-Kou Lin, et al.
British Journal of Clinical Pharmacology|May 7, 2021
Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic studyChristopher G C A Jackson, Tak Hung, Eva Segelov, et al.
Pageof 3